Berkeley HeartLab Overview

  • Year Founded
  • 1995

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 10

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $195M

Berkeley HeartLab General Information

Description

Developer of cardiovascular disease (CVD) management tools and services focusing on the secondary prevention market. The company offers clinical diagnostic tests for CVD management, including HDL and LDL gradient gel electrophoresis tests, and various genetic tests to clinicians and patients. Its testing technology enables risk characterization with relevant cardiovascular disease tests that help clinicians to develop personalized treatment recommendations, as well as allows for the therapeutic monitoring of a patient's disease.

Contact Information

Website
www.bhlinc.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 468 Littlefield Avenue
  • South San Francisco, CA 94080
  • United States
+1 (650)
Primary Industry
Biotechnology
Other Industries
Laboratory Services (Healthcare)
Other Healthcare Services
Acquirer
Vertical(s)
Corporate Office
  • 468 Littlefield Avenue
  • South San Francisco, CA 94080
  • United States
+1 (650)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Berkeley HeartLab Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 15-Oct-2007 $195M Completed Generating Revenue
4. Later Stage VC 22-Oct-2004 Completed Generating Revenue
3. Later Stage VC (Series D) 12-Aug-2004 Completed Generating Revenue
2. Later Stage VC 12-Mar-2003 $850K $8.74M Completed Generating Revenue
1. Later Stage VC (Series C) 02-Apr-2002 $7.89M $7.89M Completed Generating Revenue
To view Berkeley HeartLab’s complete valuation and funding history, request access »

Berkeley HeartLab Patents

Berkeley HeartLab Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20090118381-A1 Separation of high density lipoproteins on polymer monoliths with decreased hydrophobicity Inactive 04-Dec-2006
WO-2008070680-A1 Separation of high density lipoproteins on polymer monoliths with decreased hydrophobicity Inactive 04-Dec-2006
WO-2007092380-A2 Apolipoprotein e genotyping and accompanying internet-based health management system Inactive 06-Feb-2006
WO-2007092380-A3 Apolipoprotein e genotyping and accompanying internet-based health management system Inactive 06-Feb-2006
US-20070224619-A1 Includes a blood test that measures an apo e genotype from the patient to generate apo b information; using the information as data tool in designing physical regimen to prevent and/or alleviate cardiovascular disorders Active 06-Feb-2006 C12Q1/6883
To view Berkeley HeartLab’s complete patent history, request access »

Berkeley HeartLab Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Berkeley HeartLab Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Band of Angels Angel Group Minority
Glynn Capital Venture Capital Minority
Sippl Investments Venture Capital Minority
Steelpoint Capital Partners PE/Buyout Minority
To view Berkeley HeartLab’s complete investors history, request access »

Berkeley HeartLab FAQs

  • When was Berkeley HeartLab founded?

    Berkeley HeartLab was founded in 1995.

  • Where is Berkeley HeartLab headquartered?

    Berkeley HeartLab is headquartered in South San Francisco, CA.

  • What is the size of Berkeley HeartLab?

    Berkeley HeartLab has 10 total employees.

  • What industry is Berkeley HeartLab in?

    Berkeley HeartLab’s primary industry is Biotechnology.

  • Is Berkeley HeartLab a private or public company?

    Berkeley HeartLab is a Private company.

  • What is the current valuation of Berkeley HeartLab?

    The current valuation of Berkeley HeartLab is .

  • What is Berkeley HeartLab’s current revenue?

    The current revenue for Berkeley HeartLab is .

  • How much funding has Berkeley HeartLab raised over time?

    Berkeley HeartLab has raised $25.4M.

  • Who are Berkeley HeartLab’s investors?

    Band of Angels, Glynn Capital, Sippl Investments, and Steelpoint Capital Partners have invested in Berkeley HeartLab.

  • When was Berkeley HeartLab acquired?

    Berkeley HeartLab was acquired on 15-Oct-2007.

  • Who acquired Berkeley HeartLab?

    Berkeley HeartLab was acquired by Celera Genomics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process